Defining Complete Remission in Nephrotic Syndrome: One Size May Not Fit All Authors: Nobuo Tsuboi, Takaya Sasaki Published: 2026 To the Editor: We read with interest the recent morphometric analysis by van den Berge et al1 demonstrating that biopsy-derived structural parameters, rather than baseline clinical variables or immunosuppressive regimens, are associated with complete remission (CR) of proteinuria in primary nephrotic syndrome. By highlighting the importance of nonsclerotic glomerular density, podocyte density, and cortical fibrosis, this study underscores the central role of residual nephron reserve in determining the depth of proteinuria reduction. These results are consistent with our prior work demonstrating that nephron number is independently associated with time to CR, but not with the achievement or timing of partial remission (PR), in adult minimal change disease.2 In that cohort, PR occurred regardless of nephron number, whereas fewer nephrons were associated with delayed CR. Together, these observations support a 2-stage model in which PR primarily may reflect immunologic responsiveness, whereas progression from PR to CR may be constrained by nonimmunologic factors related to nephron reserve. This integrated perspective raises an important question: Should CR be interpreted solely as a disease-associated remission, or as a proteinuria level constrained by residual nephron capacity? In this context, persistent low-grade proteinuria after immunologic quiescence may reflect increased protein throughput per nephron rather than ongoing glomerular injury. Accordingly, rigid adherence to a uniform definition of CR may increase the risk of overtreatment, particularly in older or structurally vulnerable patients, underscoring the need for more individualized therapeutic targets. Analyses of PR-to-CR transitions in relation to morphometric indices could therefore help refine remission concepts and support personalized treatment strategies.